Duopharma Biotech expanding mobile breast cancer screening in Malaysia
Mobi Health News
JULY 25, 2023
It signed a distribution deal with UE LifeSciences to scale the access to iBreastExam in primary care clinics.
199 
Income Inequality is Fostering Mis-Trust, the Edelman 2020 Trust Barometer Observes
Health Populi
JANUARY 22, 2020
In health care, these would be our honest-and-ethical front-line workers — nurses, physicians, and pharmacists, the latest Gallup Poll on the question learned (described here in Health Populi). where private sector organizations began to more visibly take on public health objectives and missions.
Join 48,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
The Retail Health Battle Royale in the U.S. – A Week-Long Brainstorm, Day 2 of 5 – Amazon and One Medical
Health Populi
JULY 26, 2022
As we all grapple with what this means at this preliminary stage and then what could evolve over time, I focus on the dual aspect of the opportunity: is this about primary care or is this about data? To be sure, it’s both.
HealthTech M&A Multiples March 2025: Current Trends and Variables driving valuations
Lloyd Price
MARCH 1, 2025
Big Pharmas looming patent cliffs could drive outlier deals (7-8x or more) for late-stage innovators, especially in biotech-adjacent HealthTech. Telehealth Maturation and Hybrid Models Whats Happening: Telehealth is evolving beyond standalone platforms into hybrid care models, integrating with in-person services (e.g.,
2021HealthTech IPO Rush: 20+ Digital Health companies went public in 2021 but where are they now?
Lloyd Price
FEBRUARY 7, 2025
However, as with any early-stage biotech company, there's inherent risk involved, and their long-term success hinges on the successful development and commercialization of their drugs. Cano Health: Healthcare and wellness company that provides primary care medical services and pharmaceutical services.
New Insulin, Quicker Healing, Bee Endos
Insulin Nation
SEPTEMBER 15, 2014
European medical regulators have greenlighted Lilly’s long-acting insulin for sale in the EU , according to Fierce Biotech. Researchers hope this strategy, which is currently 70% accurate, can soon be utilized to uncover diabetes in people living in countries with poor primary care infrastructure…and great bee supplies.
Third Culture Capital Leads Latest Funding Round for Ciba Health
Digital Health Global
FEBRUARY 7, 2023
3CC prioritizes early-stage investments in “Third Culture entrepreneurs” whose unique perspectives have the potential to help transform healthcare and address health disparities by optimizing care delivery in healthtech and biotech.
Let's personalize your content